Join the Diabetes, Type 2 group to help and get support from people like you.
Diabetes, Type 2 News
Related terms: Noninsulin-dependent Diabetes, Type 2 Diabetes, Diabetes, Type 2
WHO Updates List of Essential Medicines to Include GLP-1s
TUESDAY, Sept. 9, 2025 – The World Health Organization published updated editions of its Model List of Essential Medicines (EML) and Essential Medicines for Children (EMLc) to include new treatments...
FDA Creates 'Green List' of GLP-1 Drug Ingredients Approved for Entry in the U.S.
FRIDAY, Sept. 5, 2025 -- The U.S. Food and Drug Administration has created a "green list" import alert to stop unapproved and unverified glucagon-like peptide 1 (GLP-1) drug ingredients from entering ...
Adults With Learning Disabilities, New Diabetes Have Shorter Time to Insulin Initiation
THURSDAY, Sept. 4, 2025 – Adults with learning disabilities and newly diagnosed type 2 diabetes (T2D) have better short-term glycemic control, but also faster progression to severe diabetes and a...
Could Diabetes Drug Metformin Change Metal Levels in Your Blood?
WEDNESDAY, Sept. 3, 2025 — The diabetes drug metformin has been a mystery for more than six decades. The most prescribed diabetes med in the world, metformin is very effective in lowering blood sugar ...
GLP-1 Receptor Agonists Linked to Reduced Risk for Developing Uveitis
TUESDAY, Sept. 2, 2025 – Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with a reduction in the risk for developing uveitis, according to a study published online Aug. 28 in...
Plant-Based Diet Protects Against Multiple Chronic Illnesses
FRIDAY, Aug. 29, 2025 — Shifting to a plant-based diet can help keep people from being plagued by multiple health problems as they age, a new study says. People whose diets included more veggies, f...
AI-Enabled Bundle of Sensors, Coaching Aids Type 2 Diabetes Outcomes
THURSDAY, Aug. 28, 2025 – An artificial intelligence (AI)-enabled bundled system of sensors and coaching facilitates significant improvements in glycemic outcomes and de-escalation of...
Breath Test For Diabetes Under Development
WEDNESDAY, Aug. 27, 2025 — Detecting diabetes might soon be as easy as breathing into a device, a new study says. An experimental breath test sorted out type 2 diabetes patients from healthy people, b...
New GLP-1 Pill, Orforglipron, Helps People Lose 23 Pounds in Study
WEDNESDAY, Aug. 27, 2025 — Eli Lilly says its new once-daily pill, orforglipron, helped people lose significant weight and lower blood sugar in a late-stage clinical trial. The company plans to seek ...
2 In 3 Women Have A Lifestyle Risk Factor For Birth Defects
TUESDAY, Aug. 26, 2025 — Two-thirds of women in their child-bearing years have an increased risk for birth defects due to a lifestyle factor they can change, a new study says. These risk factors — low...
Mediterranean Diet Can Protect Against Type 2 Diabetes
TUESDAY, Aug. 26, 2025 — A Mediterranean-style diet can significantly decrease risk of type 2 diabetes in people who are overweight or obese, a new study says. People had 31% lower odds of diabetes i...
GLP-1 Receptor Agonist Use Linked to Reduced Overall Risk for Cancer in Adults With Obesity
TUESDAY, Aug. 26, 2025 – For adults with obesity, glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is associated with a reduced overall risk for cancer, including lower risks for endometrial,...
MedDiet Plus Energy Reduction, Physical Activity Cuts Incidence of Type 2 Diabetes
TUESDAY, Aug. 26, 2025 – For individuals with overweight or obesity and metabolic syndrome, an intensive intervention combining energy reduction, the Mediterranean diet (MedDiet), and physical...
Diabetes Risk Clusters In Households
TUESDAY, Aug. 19, 2025 — Diabetes risk appears to cluster in households, a new study says. Three-quarters of people at risk for developing type 2 diabetes are living under the same roof as another p...
Diabetes Risk Commonly Clustered Within Households
TUESDAY, Aug. 19, 2025 – Diabetes risk is commonly clustered within households, according to a study scheduled to be presented at the annual meeting of the European Association for the Study of...
Further information
Related condition support groups
Related drug support groups
metformin, Ozempic, Victoza, Mounjaro, Lantus, semaglutide, Trulicity, glipizide, Rybelsus, view more... tirzepatide, Jardiance, liraglutide, Lantus Solostar, Humalog, Farxiga, Novolog, Janumet, insulin glargine, Januvia, Bydureon, insulin lispro, Tresiba, dulaglutide, Levemir, insulin degludec, Invokana, glimepiride, Glucophage, Humulin N